Chloroquine Resistance inPlasmodium vivax

Ahlm, C., J. Wistrom, and H. Carlsson. 1996. Chloroquine-resistant Plasmodium vivax in Borneo. J. Travel Med.3:124.

Akintonwa, A., M. C. Meyer, and P. T. R. Hwang. 1983. Simultaneous determination of chloroquine and desethylchloroquine in blood, plasma, and urine by high-performance liquid chromatography. J. Liquid Chromatogr.6:1513-1522.

Alcantara, A. K., C. V. Uylangco, R. P. Sangalong, and J. H. Cross. 1985. A comparative clinical study of mefloquine and chloroquine in the treatment of vivax malaria. Southeast Asian J. Trop. Med. Public Health16:534-538.

10.1590/S0037-86821999000100013

Alving, A. S., B. Craige, Jr., C. M. Worton, T. N. Pullman, and L. Eichelberger. 1948. Pentaquine, a therapeutic agent effective in reducing the relapse rate in vivax malaria. J. Clin. Investig.27(Suppl. 2):25-33.

10.1093/oxfordjournals.molbev.a026247

10.2165/00003495-200059040-00001

10.4269/ajtmh.1991.44.547

10.1093/infdis/171.6.1678

10.1016/S0035-9203(96)90528-3

Baird, J. K., D. J. Fryauff, H. Basri, M. J. Bangs, B. Subianto, I. Wiady, Purnomo, B. Leksana, S. Masbar, T. L. Richie, F. S. Wignall, and S. L. Hoffman. 1995. Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg.52:479-484.

Clin. Infect. Dis.

10.4269/ajtmh.1997.56.621

Baird, J. K., B. Leksana, S. Masbar, Suradi, M. A. Sutanihardja, D. J. Fryauff, and B. Subianto. 1997. Whole blood chloroquine concentrations with Plasmodium vivax infection in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg.56:618-620.

Baird, J. K., P. Sismadi, S. Masbar, B. Leksana, Sekartuti, A. Ramzan, and E. Tjitra. 1996. Choroquine sensitive Plasmodium falciparum and P. vivax in central Java, Indonesia. Trans. R. Soc. Trop. Med. Hyg.90:412-413.

Baird, J. K., M. F. Sustriaya Nalim, H. Basri, S. Masbar, B. Leksana, E. Tjitra, R. M. Dewi, M. Khairani, and F. S. Wignall. 1996. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. Trans. R. Soc. Trop. Med. Hyg.90:409-411.

Baird, J. K., T. Tiwari, G. J. Martin, C. L. Tamminga, T. M. Prout, J. Tjaden, P. P. Bravet, S. Rawlins, M. Ferrel, D. Carucci, and S. L. Hoffman. 2002. Chloroquine for the treatment of uncomplicated malaria in Guyana. Ann. Trop. Med. Parasitol.96:339-348.

10.4269/ajtmh.1997.56.627

Baird, J. K., I. Wiady, A. Sutanihardja, Suradi, Purnomo, H. Basri, Sekartuti, E. Ayomi, D. J. Fryauff, and S. L. Hoffman. 2002. Short report: therapeutic efficacy of chloroquine combined with primaquine against Plasmodium falciparum in northeastern Papua, Indonesia. Am. J. Trop. Med. Hyg.66:659-660.

Berliner, R. W., D. P. Earle, Jr., J. V. Taggart, C. G. Zubrod, W. J. Welch, N. J. Conan, E. Bauman, S. T. Scudder, and J. A. Shannon. 1948. Studies on the chemotherapy of the human malarias. VI. The physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinoline. J. Clin. Investig.27:98-107.

10.1016/S0378-4347(00)86110-1

Chemotherapy of malaria 2nd ed. World Health Organization monograph series no. 27 1981

Boudreau, E. F., L. W. Pang, S. Chaikummao, and C. Witayarut. 1991. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar) and chloroquine as malarial prophylaxis in eastern Thailand. Southeast Asian J. Trop. Med. Public Health22:183-189.

Brockelman, C. R., P. Tan-Ariya, and D. Bunnag. 1989. Development of in vitro microtest for the assessment of Plasmodium vivax sensitivity to chloroquine. Southeast Asian J. Trop. Med. Public Health20:41-47.

Brodie, B. B., S. Udenfriend, W. Dill, and G. Downing. 1947. The estimation of organic compounds in biological material. II. Estimation of fluorescent compounds. J. Biol. Chem.168:319-325.

Bruce, M. C., M. R. Galinski, J. W. Barnwell, G. Snounou, and K. P. Day. 1999. Polymorphism at the merozoite surface protein-3α locus of Plasmodium vivax: global and local diversity. Am. J. Trop. Med. Hyg.61:518-525.

Butts, D. C. A. 1950. Results on 449 cases of naturally acquired malaria treated with chloroquine. J. Natl. Malaria Soc.9:44-49.

Campbell, C. C. 1997. Malaria: an emerging and re-emerging global plague. FEMS Immunol. Med. Microbiol.18:325-331.

Canada Communicable Disease Report. 2000. Canadian recommendations for the prevention and treatment of malaria among international travelers vol. 26 suppl. 2. CATMAT Toronto Ontario Canada.

Castillo, C. M., L. E. Osorio, and G. I. Palma. 2002. Assessement of therapeutic response of Plasmodium vivax and Plasmodium falciparum to chloroquine in a malaria transmission-free area of Colombia. Mem. Inst. Oswaldo Cruz97:559-562.

Chai, J. Y. 1999. Re-emerging Plasmodium vivax in the Republic of Korea. Korean J. Parasitol.37:129-143.

10.4269/ajtmh.1963.12.121

Coatney, G. R., W. C. Cooper, and M. D. Young. 1950. Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections by the Chesson strain of Plasmodium vivax. J. Natl. Malaria Soc.9:381-396.

Coatney, G. R., D. S. Ruhe, W. C. Cooper, E. S. Josephson, and M. D. Young. 1949. Studies in human malaria. X. The protective and therapeutic action of chloroquine (SN 7618) against St. Elizabeth strain of vivax malaria. Am. J. Hyg.49:49-59.

10.1093/infdis/164.1.222

Collins, W. E., I. K. Schwartz, J. C. Skinner, C. Morris, and V. K. Filipski. 1992. The susceptibility of the Indonesian I/CDC strain of Plasmodium vivax to chloroquine. J. Parasitol.78:344-349.

Collins, W. E., J. S. Sullivan, D. J. Fryauff, J. Kendall, V. Jennings, G. G. Galland, and C. L. Morris. 2000. Adaptation of a chloroquine-resistant strain of Plasmodium vivax from Indonesia to New World monkeys. Am. J. Trop. Med. Hyg.62:491-495.

10.1016/S0001-706X(02)00090-6

Cooper, R. D., W. K. Milhous, and K. H. Rieckmann. 1994. The efficacy of WR238605 against the blood stages of a chloroquine-resistant strain of Plasmodium vivax. Trans. R. Soc. Trop. Med. Hyg.88:691-692.

Craig, A. A., and K. C. Kain. 1996. Molecular analysis of Plasmodium vivax from paired primary and relapse infections. J. Infect. Dis.174:373-379.

10.1093/infdis/80.3.228

Davis, T. M., D. A. Syed, K. F. Ilett, and P. H. Barrett. 2003. Toxicity related to chloroquine treatment of resistant vivax malaria. Ann. Pharmacother.37:526-529.

Dixon, K. E., U. Pitaktong, and P. Phintuyothin. 1985. A clinical trial of mefloquine in the treatment of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg.34:435-437.

Dua, V. K., P. K. Kar, and V. P. Sharma. 1996. Chloroquine-resistant Plasmodium vivax malaria in India. Trop. Med. Int. Health1:816-819.

10.1126/science.101.2624.377

10.1073/pnas.1232502100

10.1007/BF00542151

Fryauff, D. J., J. K. Baird, H. Basri, I. Sumawinata, Purnomo, T. L. Richie, C. K. Ohrt, E. Mouzin, C. J. Church, A. L. Richards, F. S. Wignall, and S. L. Hoffman. 1995. Randomized placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet346:1190-1193.

10.4269/ajtmh.1997.56.241

Fryauff, D. J., B. Leksana, S. Masbar, I. Wiady, P. Sismadi, A. I. Susanti, H. S. Nagesha, Syafruddin, S. Atmosoedjono, M. J. Bangs, and J. K. Baird. 2002. The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia. Ann. Trop. Med. Parasitol.96:447-462.

Fryauff, D. J., Soekartono, S. Tuti, B. Leksana, Suradi, S. Tandayu, and J. K. Baird. 1998. Survey of resistance in vivo to chloroquine of Plasmodium falciparum and P. vivax in North Sulawesi, Indonesia. Trans. R. Soc. Trop. Med. Hyg.92:82-83.

10.4269/ajtmh.1999.60.542

Fryauff, D. J., S. Tuti, A. Mardi, S. Masbar, R. Patipehohi, B. Leksana, K. C. Kain, M. J. Bangs, T. L. Richie, and J. K. Baird. 1998. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am. J. Trop. Med. Hyg.59:513-518.

Fu, S., A. Bjorkman, D. Ofori-Adjei, B. Wahlin, O. Ericcson, and F. Sjoqvist. 1986. In vitro activity of chloroquine, the two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum. Br. J. Pharmacol.22:93-96.

10.1016/0035-9203(84)90145-7

10.1016/0035-9203(95)90432-8

Geary, T. G., A. A. Divo, and J. B. Jenson. 1987. Activity of quinoline antimalarials against chloroquine-sensitive and -resistant strains of Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg.81:499-503.

Gordon, H. H., F. R. Dieuaide, A. Marble, H. B. Christianson, and L. K. Dahl. 1947. Treatment of Plasmodium vivax malaria of foreign origin. Arch. Intern. Med.79:365-378.

Gustafsson, L. L., L. Rombo, G. Alvan, A. Bjorkman, M. Lind, and O. Walker. 1983. On the question of dose-dependent chloroquine elimination of a single oral dose. Clin. Pharmacol. Ther.34:383-385.

Hamedi, Y., M. Nateghpour, P. Tan-ariya, M. Tiensuwan, U. Silachamroon, and S. Looareesuwan. 2002. Plasmodium vivax malaria in southeast Iran in 1999-2001: establishing the response to chloroquine in vitro and in vivo. Southeast Asian J. Trop. Med. Public Health33:512-518.

Hanna, J. 1993. Chloroquine-resistant Plasmodium vivax: how common? Med. J. Aust.158:502-503.

Harinasuta, T., D. Bunnag, R. Lasserre, R. Leimer, and S. Vinijanont. 1985. Trials of mefloquine in vivax and of mefloquine plus Fansidar in falciparum malaria. Lanceti:885-888.

10.1073/pnas.182295999

10.1086/381397

Hoekenga, M. T. 1952. Treatment of malaria with a single dose of amodiaquine or chloroquine. JAMA149:1369-1371.

Jamaiah, I., A. K. Anuar, N. A. Najib, and M. N. Zurainee. 1998. Imported malaria: a retrospective study in University Hospital, Kuala Lumpur, a ten-year experience. Med. J. Malaysia53:6-9.

Kirchgatter, K., and H. A. del Portillo. 1998. Molecular analysis of Plasmodium vivax relapses using the MSP1 molecule as a genetic marker. J. Infect. Dis.177:511-515.

Kocken, C. H., A. van der Wel, B. Rosenwirth, and A. W. Thomas. 1996. Plasmodium vivax: in vitro antiparasitic effect of cyclosporins. Exp. Parasitol.84:439-443.

Kshirsagar, N. A., N. J. Gogtay, D. Rojgor, S. S. Dalvi, and M. Wakde. 2000. An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India. Ann. Trop. Med. Parasitol.94:189-190.

Lacy, M. D., J. D. Maguire, M. J. Barcus, J. Ling, M. J. Bangs, R. Gramzinski, H. Basri, P. Sismadi, G. B. Miller, J. D. Chulay, D. J. Fryauff, S. L. Hoffman, and J. K. Baird. 2002. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity. Clin. Infect. Dis.35:e92-e95.

Loeb, R. F., W. M. Clark, G. R. Coatney, L. T. Coggeshall, F. R. Dieuaide, A. R. Dochez, E. G. Hakansson, E. K. Marshall, Jr., C. S. Marvel, O. R. McCoy, J. J. Sapero, W. H. Sebrell, J. A. Shannon, and G. A. Carden. 1946. Activity of a new antimalarial agent, chloroquine (SN 7618). JAMA130:1069-1070.

10.1080/00034983.1999.11813417

Looareesuwan, S., T. Harinasuta, and T. Chongsuphajaisiddhi. 1992. Drug resistant malaria with special reference to Thailand. Southeast Asian J. Trop. Med. Public Health23:621-634.

Machado, R. L. D., A. F. Filho, V. S. P. Calvosa, M. C. Figueredo, J. M. Nascimento, and M. M. Povoa. 2003. Correlation between Plasmodium vivax variants in Belem, Para State, Brazil and symptoms and clearance of parasitemia. Braz. J. Infect. Dis.7:175-177.

Maguire, J. D., M. D. Lacy, Sururi, P. Sismadi, Krisin, I. Wiady, B. Laksana, M. J. Bangs, S. Masbar, I. Susanti, W. Basuki, M. J. Barcus, H. Marwoto, M. D. Edstein, S. Tjokrosonto, and J. K. Baird 2002. Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia. Ann. Trop. Med. Parasitol.96:655-668.

10.1016/0035-9203(95)90556-1

McChesney, E.W., W. F. Banks, Jr., and J. P. McAuliff. 1962. Laboratory studies of the 4-aminoquinoline antimalarials. II. Plasma levels of chloroquine and hydroxychloroquine in man after various oral dosage regimens. Antibiot. Chemother.12:583-594.

Medical Letter on Drugs and Therapeutics. 2002. Drugs for parasitic infections April p. 6. The Medical Letter Inc. New Rochelle N.Y.

Mendis, K., B. J. Sina, P. Machesini, and R. Carter. 2001. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg.64S:97-106.

10.1001/jama.1946.02870290013005

Murphy, G. S., H. Basri, Purnomo, E. M. Andersen, M. J. Bangs, D. L. Mount, J. Gorden, A. A. Lal, A. R. Purwokusumo, S. Harjosuwarno, K. Sorensen, and S. L. Hoffman. 1993. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet341:96-100.

10.1016/0035-9203(93)90294-Z

10.1086/320707

Obaldia, N., III, R. N. Rossan, R. D. Cooper, D. E. Kyle, E. O. Nuzum, K. H. Rieckmann, and G. D. Shanks. 1997. WR238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys. Am. J. Trop. Med. Hyg.56:508-510.

10.7326/0003-4819-126-12-199706150-00006

Patchen, L. C., D. L. Mount, I. K. Schwartz, and F. C. Churchill. 1983. Analysis of filter paper absorbed finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection. J. Chromatogr.278:81-89.

Phan, G. T., P. J. de Vries, B. Q. Tran, H. Q. Le, N. V. Nguyen, T. V. Nguyen, S. H. Heisterkamp, and P. A. Kager. 2002. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam. Trop. Med. Int. Health2:858-864.

10.1093/clinids/23.5.1171

Potkar, C. N., N. A. Kshirsagar, and R. Kathuria. 1995. Resurgence of malaria and drug resistance in Plasmodium falciparum and Plasmodium vivax species in Bombay. J. Assoc. Physicians India43:336-338.

10.4269/ajtmh.1974.23.1007

Price, R. N., and F. Nosten. 2001. Drug resistant falciparum malaria: clinical consequences and strategies for prevention. Drug Resist. Update4:187-196.

Pullman, T. N., B. Craige, Jr., A. S. Alving, C. M. Whorton, R. Jones, Jr., and L. Eichelberger. 1948. Comparison of chloroquine, quinacrine, and quinine in the treatment of acute attacks of sporozoite-induced vivax malaria (Chesson strain). J. Clin. Investig.27:46-50.

10.1159/000238664

10.1016/S0140-6736(89)91792-3

Rombo, L., Y. Berqvist, and U. Hellgren. 1987. Chloroquine and desethylchloroquine concentrations during regular and long-term malaria prophylaxis. Bull. W. H. O.65:879-883.

Rombo, L., O. Ericsson, G. Alvan, B. Lindstrom, and L. L. Gustafsson. 1985. Chloroquine and desethylchloroquine in plasma, serum and whole blood: problems in assay and handling of samples. Ther. Drug Monit.7:211-215.

10.4269/ajtmh.2003.69.548

10.1128/AAC.47.1.170-173.2003

10.1016/0035-9203(92)90531-G

Schuurkamp G. J. T. 1992. Ph.D. dissertation. University of Papua New Guinea.

Schwartz, I. K., E. M. Lackritz, and L. C. Patchen. 1991. Chloroquine-resistant Plasmodium vivax from Indonesia. N. Engl. J. Med.324:927.

10.4269/ajtmh.2001.65.90

Sumawinata, I. W., Bernadeta, B. Leksana, A. Sutamihardja, Purnomo, B. Subianto, Sekartuti, D. J. Fryauff, and J. K. Baird. 2002. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am. J. Trop. Med. Hyg.68:416-420.

Tan-ariya, P., K. Na-Bangchang, T. Tin, L. Limapibul, C. R. Brockelman, and J. Karbwang. 1995. Clinical response and susceptibility in vitro of Plasmodium vivax to the standard regimen of chloroquine in Thailand. Trans. R. Soc. Trop. Med. Hyg.89:426-429.

10.1016/S0001-706X(02)00056-6

10.4269/ajtmh.2000.62.693

10.4269/ajtmh.2001.64.223

Van Den Abbeele, K., E. Van Den Enden, and J. Van Den Ende. 1995. Combined chloroquine and primaquine resistant Plasmodium vivax malaria in a patient returning from India. Ann. Soc. Belge Med. Trop.75:73-74.

Verdier, F., J. Le Bras, F. Clavier, and I. Hatin. 1984. Blood levels and in vitro activity of desethylchloroquine against Plasmodium falciparum. Lanceti:1186-1187.

Villalobos-Salcedo, J. M., M. S. Tada, E. Kimura, M. J. Menezes, and L. H. Pereira-da-Silva. 2000. In-vivo sensitivity of Plasmodium vivax isolates from Rondonia (western Amazon region, Brazil) to regimens including chloroquine and primaquine. Ann. Trop. Med. Parasitol.94:749-758.

10.1086/322858

Whitby, M., G. Wood, J. R. Veenendaal, and K. Rieckmann. 1989. Chloroquine-resistant Plasmodium vivax. Lancetii:1395.

Whorton, C. M., E. Yount, Jr., R. Jones, Jr., A. S. Alving, T. N. Pullman, B. Craige, Jr., and L. Eichelberger. 1950. Studies in human malaria. The Chesson strain of Plasmodium vivax malaria. III. Clinical aspects. J. Infect. Dis.80:237-249.

Wilson, T., and J. F. B. Edeson. 1954. Studies on the chemotherapy of malaria. III. The treatment of acute malaria with chloroquine. Med. J. Malaya9:114-131.

Wiselogle F. Y. 1946. A survey of antimalarial drugs 1941-1945 2 vols. J. W. Edwards Ann Arbor Mich.

World Health Organization. 2001. The use of antimalarial drugs. Report of a WHO informal consultation. Report WHO/CDS/RBM/2001.33. World Health Organization Geneva Switzerland.